Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL927

CEFDINIR
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1

Basic Information

ChEMBL ID CHEMBL927
Name CEFDINIR
Phase Approved
Structure Type MOL
InChI Key RTXOFQZKPXMALH-GHXIOONMSA-N
Therapeutic ✓ Yes

Known Names

BMY-28488 Cefdinir Cefdinir anhydrous Cefzon CI-983 FK 482 FK-482 NSC-758926 Omnicef
5
Targets
14
Activities
3
Assay Types
12
PK Parameters
20
Publications
9
Known Names
11
Indications
1
Mechanisms

Molecular Properties

395.4
MW (Da)
-0.17
ALogP
9
HBA
4
HBD
158.2
PSA (Ų)
0.23
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1997
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Natural Product
USAN Stem cef-
USAN Year 1991

Extended Properties

Molecular Formula C14H13N5O5S2
MW 395.42
Aromatic Rings 1
Heavy Atoms 26
NP-Likeness 0.05

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Bacterial penicillin-binding protein inhibitor INHIBITOR Bacterial penicillin-binding protein

Indications

Bacterial Infections Bronchitis, Chronic Infections Otitis Media Otitis Media Pharyngitis Pneumonia Tonsillitis Mastitis Appendicitis Osteomyelitis

ATC Classification

J01DD15
cefdinir
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIBACTERIALS FOR SYSTEMIC USE

Activity Summary

IC50 9 meas. best 5.35
EC50 3 meas. best 6.28
Ki 2 meas.

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
EC50 6.28 6.28 521.0 1
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1
CHEMBL1795098
IC50 5.35 5.35 4480.0 1
ATP-binding cassette sub-family C member 4
CHEMBL1743128
IC50 4.94 4.94 11600.0 1
Unchecked
CHEMBL612545
IC50 4.81 4.59 15360.0 6
Zinc finger protein mex-5
CHEMBL1293319
EC50 4.48 4.48 33257.0 1
RNA-binding protein pos-1
CHEMBL1293304
EC50 4.3 4.3 49794.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 10000.0 ng.hr.mL-1 Mus musculus
AUC 13200.0 ng.hr.mL-1 Rattus norvegicus
AUC 64200.0 ng.hr.mL-1 Oryctolagus cuniculus
Cmax 6322.39 nM Mus musculus
Cmax 15173.74 nM Rattus norvegicus
Cmax 14667.95 nM Oryctolagus cuniculus
T1/2 0.6 hr Mus musculus
T1/2 1.5 hr Rattus norvegicus
T1/2 1.9 hr Oryctolagus cuniculus
Tmax 1.0 hr Mus musculus
Tmax 2.0 hr Rattus norvegicus
Tmax 1.0 hr Oryctolagus cuniculus

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
19307366 10.1128/aac.01531-08 Streptococcus pneumoniae 52
17908940 10.1128/aac.00971-07 Streptococcus pneumoniae 34
18443117 10.1128/aac.00310-08 Streptococcus pneumoniae 27
17325223 10.1128/aac.01545-06 Haemophilus influenzae 20
17116666 10.1128/aac.01150-06 Streptococcus pneumoniae 20
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
18955529 10.1128/aac.00402-08 Haemophilus influenzae 12
20585130 10.1128/aac.00054-10 Haemophilus influenzae 12
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
17908940 10.1128/aac.00971-07 Haemophilus influenzae 9
15646539 10.1016/s0399-8320(04)95062-2 NON-PROTEIN TARGET 8
17325223 10.1128/aac.01545-06 NON-PROTEIN TARGET 7
19124661 10.1128/aac.01519-08 Enterobacteriaceae 6
- 10.1016/S0960-894X(01)80929-X ADMET 5
- 10.1016/S0960-894X(01)80929-X Rattus norvegicus 5
- 10.1016/S0960-894X(01)80929-X Mus musculus 5
10999485 10.1016/s0960-894x(00)00425-x NON-PROTEIN TARGET 4
37167780 10.1016/j.ejmech.2023.115452 Staphylococcus aureus 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
18347113 10.1128/aac.00936-07 Haemophilus influenzae 3

Data from ChEMBL 36 via Core Engine